Nurse Practitioner · New York, NY
NPI
1750690863
Since 2010
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Avenue, Bmt Clinic
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
270 services
Medicare patients, 2024
146
Average age 72
Drug cost, 2024
$3.6M
639 prescriptions
Company payments, 2024
$99.95
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shani N Irby was code 99213 (office e&m - established), 97 times for 47 patients. In total Shani N Irby billed 270 services in 9 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 97 | 47 | $50.56 | $4,904 |
| 99214 Office E&M - Established | Office | 68 | 38 | $72.65 | $4,940 |
| 38222 Other Organ Systems | Office | 67 | 61 | $53.78 | $3,603 |
| 38222 Other Organ Systems | Facility | 21 | 21 | $55.97 | $1,175 |
By year: 2022 $13K for 145 services; 2023 $24K for 335 services; 2024 $16K for 270 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shani N Irby prescribed most often to Medicare patients was Lenalidomide, with 117 prescriptions and refills. In total Shani N Irby wrote 639 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 117 | 117 | 19 | $1.5M |
| Acyclovir Generic | 62 | 139 | 23 | $1,223 |
| Jakafi Ruxolitinib Phosphate | 44 | 44 | Under 11 | $350K |
| Revlimid Lenalidomide | 34 | 34 | Under 11 | $640K |
| Zarxio Filgrastim-Sndz | 33 | 33 | 25 | $162K |
| Gabapentin Generic | 27 | 29 | Under 11 | $258 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 43 | 11 | $153 |
| Pomalyst Pomalidomide | 23 | 23 | 12 | $473K |
| Ondansetron Hcl Generic | 22 | 22 | 22 | $81.75 |
| Lorazepam Generic | 16 | 16 | Under 11 | $15.77 |
| Colesevelam Hcl Generic | 15 | 25 | Under 11 | $402 |
| Alprazolam Generic | 13 | 13 | Under 11 | $59.15 |
| Atovaquone Generic | 12 | 12 | Under 11 | $7,946 |
| Pantoprazole Sodium Generic | 11 | 31 | Under 11 | $307 |
| Xarelto Rivaroxaban | 11 | 11 | Under 11 | $6,305 |
Brand drugs: - claims; generic drugs: 433 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Shani N Irby $99.95 ($99.95 in general payments such as food, travel and fees) from 1 company. The largest payer was Incyte Corporation with $99.95.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $99.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.